Drug Shows Promise for FSGS

Sparsentan, a novel dual-action drug, shows promise for the treatment of focal segmental glomerulosclerosis (FSGS), a kidney disease for which no FDA-approved pharmacotherapy exists, researchers reported at the American Society of Nephrology's 2016 Kidney Week meeting.

Prostate Cancer Risk Lower With HIV

HIV-infected men on antiretroviral therapy have a lower incidence of prostate cancer (PCa) compared with those in the general population, new study findings suggest.

Kidney Week 2016 Conference

Get a sneak peek of happenings at the American Society of Nephrology's Kidney Week 2016.

Omega-3s May Explain HD Obesity Paradox

Omega-3 fatty acids may explain the obesity paradox observed in patients with advanced chronic kidney disease (CKD), according to study findings presented at the American Society of Nephrology's 2016 Kidney Week meeting.

Hyperkalemia Boxed Warning Removed

The FDA has approved removal of a boxed warning from the patiromer (Veltassa) drug label related to the timing of drug administration.

Early RRT for AKI Beneficial

Early initiation of renal replacement therapy (RRT) for acute kidney injury (AKI) in critically ill patients may decrease dependence on long-term dialysis, investigators reported at the American Society of Nephrology's 2016 Kidney Week meeting.

Hypogonadism May Up PCa Progression

Hypogonadism in prostate cancer patients eligible for active surveillance is associated with an elevated risk of disease progression, according to researchers.

Constipation Linked With CKD, ESRD

Chronic kidney disease (CKD) and end-stage renal disease (ESRD) are more likely to develop in individuals with constipation than in those with normal bowel movements.

Less Meat May Prevent Kidney Stones

When it comes to preventing kidney stones with diet, protein type and acid load may matter.

HIPAA: Protecting Computers From Hacking

Medical practices can take a number of steps either on their own or with the help of IT firms to make it more difficult to hack into a practice's computer files.

Benchmarking Essentials

With healthcare payers' focus on patient satisfaction and move toward pay for performance, it is imperative to know where your practice stands.

CME: SGLT-2 Inhibitors for Type 2 ...

Increased clinical research has been focused on the sodium-glucose co-transporter 2 (SGLT-2) inhibitors for the management of type 2 diabetes.

Looking for a Job?

Access our job board to view over 1,000 job openings throughout the US.

RUN Social Media Survey

Tell us about your social media habits for a chance to win a free gift card.


Sign Up for Free e-newsletters